Form 8-K - Current report:
SEC Accession No. 0000950170-22-002538
Filing Date
2022-03-01
Accepted
2022-03-01 16:16:37
Documents
13
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kod-20220301.htm   iXBRL 8-K 52856
2 EX-99.1 kod-ex99_1.htm EX-99.1 156830
  Complete submission text file 0000950170-22-002538.txt   336954

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kod-20220301_pre.xml EX-101.PRE 9578
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kod-20220301_lab.xml EX-101.LAB 12936
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kod-20220301.xsd EX-101.SCH 2483
7 EXTRACTED XBRL INSTANCE DOCUMENT kod-20220301_htm.xml XML 4514
Mailing Address 1200 PAGE MILL RD PALO ALTO CA 94304
Business Address 1200 PAGE MILL RD PALO ALTO CA 94304 650-281-0850
Kodiak Sciences Inc. (Filer) CIK: 0001468748 (see all company filings)

EIN.: 270476525 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38682 | Film No.: 22698235
SIC: 2836 Biological Products, (No Diagnostic Substances)